Profil
Dr. Emil T.
Kuriakose, MD, is a Chief Medical Officer-Oncology at Terns Pharmaceuticals, Inc. Dr. Kuriakose was previously employed as a Chief Medical Officer by Calithera Biosciences, Inc. and a Medical Director by Novartis Oncology, Inc. He received his undergraduate degree from New York University and a doctorate degree from Stony Brook University School of Medicine.
Aktive Positionen von Emil Kuriakose
| Unternehmen | Position | Beginn |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
Ehemalige bekannte Positionen von Emil Kuriakose
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
| CALITHERA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Emil Kuriakose
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Stony Brook University School of Medicine
Stony Brook University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
















